Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years

Novel Designs and End Points for Phase II Clinical Trials

(2009) A. A. Adjei et al.   CLINICAL CANCER RESEARCH

Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

(2009) Martee L. Hensley et al.   GYNECOLOGIC ONCOLOGY

Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas

(2009) Suzanne George et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

(2009) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

(2009) Rashmi Chugh et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

(2009) Robert G. Maki et al.   JOURNAL OF CLINICAL ONCOLOGY

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

(2009) Stefan Sleijfer et al.   JOURNAL OF CLINICAL ONCOLOGY

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma

(2008) Vasilios Karavasilis et al.   CANCER

Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study

(2008) Virginia Ferraresi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Publication biases and phase II trials investigating anticancer targeted therapies

(2008) Nicolas Penel et al.   INVESTIGATIONAL NEW DRUGS

Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma

(2008) Laurence H. Baker et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

(2008) Nicolas Penel et al.   JOURNAL OF CLINICAL ONCOLOGY

Other Endpoints in Screening Studies for Soft Tissue Sarcomas

(2008) J. Verweij   ONCOLOGIST

A Phase II Study of Gefitinib for Patients with Advanced HER-1 Expressing Synovial Sarcoma Refractory to Doxorubicin-Containing Regimens

(2008) I. Ray-Coquard et al.   ONCOLOGIST